** Shares of drugmaker AbbVie ABBV.N rise 3.5% to $196 premarket
** AbbVie raises its annual adj. profit per share to between $11.88 and $12.08, from previous expectations of $11.67 to $11.87
** Company earned quarterly profit per share of $2.97 compared with analysts' average estimates of $2.88 per share - data compiled by LSEG
** AbbVie's second-quarter revenue came in at $15.42 billion vs estimate of $15.03 billion
** Skyrizi recorded Q2 sales of $4.42 billion, beating estimates of $4 billion while Rinvoq sales of $2.03 billion topped estimates of $1.97 billion
** Up to last close, stock up 6.5% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.